Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on December 26, 2006

Circulation. 2006
Published online before print December 26, 2006, doi: 10.1161/CIRCULATIONAHA.106.657601
A more recent version of this article appeared on January 16, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/2/196    most recent
CIRCULATIONAHA.106.657601v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ko, D. T.
Right arrow Articles by Tu, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ko, D. T.
Right arrow Articles by Tu, J. V.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Health policy and outcome research
Right arrow Other Ethics and Policy
Right arrow Heart failure - basic studies
Right arrow Acute myocardial infarction
Right arrow Epidemiology

Submitted on August 23, 2006
Accepted on October 19, 2006

Regional Differences in Process of Care and Outcomes for Older Acute Myocardial Infarction Patients in the United States and Ontario, Canada

Dennis T. Ko MD, MSc, Harlan M. Krumholz MD, SM, Yongfei Wang MS, JoAnne M. Foody MD, Fredrick A. Masoudi MD, MSPH, Edward P. Havranek MD, John J. You MD, David A. Alter MD, PhD, Therese A. Stukel PhD, Alice M. Newman MS, and Jack V. Tu MD, PhD*

From the Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre (D.T.K., D.A.A., J.V.T.), Institute for Clinical Evaluative Sciences (D.T.K., J.J.Y., D.A.A., T.A.S., A.M.N., J.V.T.), Toronto, Ontario, Canada; Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine (H.M.K., Y.W.), Section of Health Policy and Administration, Department of Epidemiology and Public Health (H.M.K.), Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine (H.M.K.), and the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K.), New Haven, Conn; Yale University School of Medicine, Section of Cardiovascular Medicine, West Haven Veteran’s Administration Medical Center, West Haven, CT Qualidigm, Middletown, Conn (J.M.F.); Department of Medicine, Denver Health Medical Center (F.A.M., E.P.H.), Department of Medicine, University of Colorado Health Sciences Center (F.A.M., E.P.H.), Denver, Col; Center for the Evaluative Clinical Sciences, Dartmouth Medical School, Hanover, NH (T.A.S.); and Division of General Internal Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada (J.V.T.).

* To whom correspondence should be addressed. E-mail: tu{at}ices.on.ca.

Background--Previous comparisons of acute myocardial infarction (AMI) treatment between the United States and Canada are limited because they compared selected patients from randomized trials, used administrative data that lacked clinical detail, or did not consider regional differences in AMI treatment.

Methods and Results--We compared medication use, invasive cardiac procedure use, and 30-day risk-standardized mortality rates of 38 886 fee-for-service Medicare beneficiaries hospitalized with AMI in the United States and 5634 similarly aged patients in Ontario, Canada, from 1998 and 2001. Baseline characteristics and illness severity across the US regions and Ontario were not substantially different. Cardiac catheterization use in AMI patients was significantly higher in the United States compared with Ontario (38.7% versus 16.8%, P<0.001), but significant regional variations existed, in which the northeastern United States had significantly lower utilization rates (25.6%) compared with other US regions. {beta}-Blocker use among ideal candidates was highest in the northeastern United States (77.6% versus 69.7% in the United States as a whole, P<0.001) and angiotensin-converting enzyme inhibitor use was highest in Ontario (69.1% versus 58.2% in the United States, P<0.001). Risk-standardized mortality rates at 30 days were not substantially different across the regions.

Conclusions--Previous studies have suggested a clear divergence in invasive cardiac therapy for AMI patients between the United States and Canada on the basis of health care financing and structural differences. Our findings of similar treatment patterns in the northeastern United States and Ontario suggest that regional practices may have a greater impact on treatment patterns than the respective health care delivery systems.


Key words: outcomes • myocardial infarction • heart catheterization




This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
T. R. Vogel, J. C. Cantor, V. Y. Dombrovskiy, P. B. Haser, and A. M. Graham
AAA Repair: Sociodemographic Disparities in Management and Outcomes
Vascular and Endovascular Surgery, January 1, 2009; 42(6): 555 - 560.
[Abstract] [PDF]


Home page
CirculationHome page
J. V. Tu and D. T. Ko
Ecological Studies and Cardiovascular Outcomes Research
Circulation, December 9, 2008; 118(24): 2588 - 2593.
[Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
G. F. Anderson and B. K. Frogner
Health Spending In OECD Countries: Obtaining Value Per Dollar
Health Aff., November 1, 2008; 27(6): 1718 - 1727.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. S. Ross and A. S. Detsky
Comparison of the US and Canadian Health Care Systems: A Tale of 2 Mount Sinai's
JAMA, October 22, 2008; 300(16): 1934 - 1936.
[Full Text] [PDF]


Home page
CirculationHome page
B. K. Nallamothu, R. A. Hayward, and E. R. Bates
Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies
Circulation, September 16, 2008; 118(12): 1294 - 1303.
[Full Text] [PDF]


Home page
CirculationHome page
D. W. Jones, E. D. Peterson, R. O. Bonow, F. A. Masoudi, G. C. Fonarow, S. C. Smith Jr, P. Solis, M. Girgus, P. C. Hinton, A. Leonard, et al.
Translating Research Into Practice for Healthcare Providers: The American Heart Association's Strategy for Building Healthier Lives, Free of Cardiovascular Diseases and Stroke
Circulation, August 5, 2008; 118(6): 687 - 696.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. M. Krumholz
Outcomes Research: Generating Evidence for Best Practice and Policies
Circulation, July 15, 2008; 118(3): 309 - 318.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. T. Ko, Y. Wang, D. A. Alter, J. P. Curtis, S. S. Rathore, T. A. Stukel, F. A. Masoudi, J. S. Ross, J. M. Foody, and H. M. Krumholz
Regional Variation in Cardiac Catheterization Appropriateness and Baseline Risk After Acute Myocardial Infarction.
J. Am. Coll. Cardiol., February 19, 2008; 51(7): 716 - 723.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Kaul and E.D. Peterson
The Cardiovascular World Is Definitely Not Flat
Circulation, January 16, 2007; 115(2): 158 - 160.
[Full Text] [PDF]